Skip to main content
The ORION team ran a session on "How can art and gaming spur public engagement in Science" at the Swedish HSS 2021 conference on 6 May at 13:20 CET. The theme for this year's conference is "Collaboration across borders". During the session we showcased the Artist in residency project, the art work AEON - Trajectories of CRISPR and longevity" as well as the VACCINE gaming project.

Read more...

The findings of the ORION public dialogue on genome editing in life sciences research were presented at an event on 11th March 2021. The findings bring together four public dialogue events held in the United Kingdom, Germany, Sweden and Czech Republic during 2019-2020. The dialogues sought to explore public attitudes to fundamental life sciences research when revolutionary genome editing technologies are used in order to understand when and how to engage audiences with emerging technologies. The public dialogue also sought to understand how public engagement strategies might differ between countries.

Read more...

The annual Open Science conference arranged by the Leibniz Research Alliance Open Science, provides a unique forum for stakeholders to discuss the latest and future developments in Open Science. The ORION project will be showcased during the conference on 11-12 March.

Read more...

Would you take daily inhalations to stay young? In her work “ÆON. Trajectories of Longevity and CRISPR,” the artist Emilia Tikka constructs a poetic scenario of a possible future. The installation is exhibited at the National Museum of Science and Technology in Stockholm from 23 January 2020.

Read more...

Art is a powerful tool to reach people. Since prehistoric times, humans have used art to tell stories, communicate complex ideas and express emotions. Now, scientists and science communicators are increasingly using diverse art forms to convey science to the public. Join our inspirational session at the Forum for Science Communication.

Read more...

Eternal life through genome editing?

If there was a medicine that could stop physical ageing – would you take it? Artist Emilia Tikka’s installation, which is showcased at the Swedish National Museum of Science and Technology in Stockholm, uses this idea to stage a vision of the future. The artwork is the result of her collaboration with researchers in the field of genome editing. The exhibition was opened with a seminar on 23 January 2020.

Inspiring story - Using Art as a way to level the playing field when discussing science

Can art help to explain scientific concepts? During the course of the ORION project, artist Emilia Tikka designed an art piece to represent a possible future scenario where it was possible to prevent aging using genome editing. The art piece was produced by Tikka while she was on a residency with the ORION partner, the Max Delbrück Center for Molecular Medicine in Berlin. There she spent time in a molecular biology lab and developed the concept for her art piece titled “ÆON - Trajectories of Longevity and CRISPR.”

New ways to opening up life sciences research 

How can you establish cultural change? How do you implement and embed Open Science and Responsible Research and Innovation (RRI) in your organisation? These are the questions that the ORION project aims to answer. From the start of the project in 2017, ORION has been exploring how to establish an open dialogue with society on relevant research topics, such as genome editing, and has been developing new ways and collaborations between researchers and the general public. Co-creation is at heart of the ORION project.

Public dialogue to spur engagement? ORION at Engage Festival 2020

The online Engage Festival, organised by the National Coordinating Centre for Public Engagement (NCCPE) in the UK brought together public engagement and science communication professionals from all over the UK and the EU for discussions, knowledge exchange and networking. The ORION project ran a session to share experiences of how public dialogues could be a tool for public engagement on societal issues such as genome editing.